COMPOSITION FOR TREATING TUBERCULOSIS

medicine. SUBSTANCE: composition contains tuberculostatic preparation rifampicin, target additives the main magnesium carbonate or calcium carbonate, calcium or magnesium stearate, milk sugar and a foundation as cacao butter and beeswax, fatty foundation linoleic foundation, "vitepsol H- 15&quo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MOLDAVER B.L, BORISOVA O.A, ALEKSANDROVA A.E
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:medicine. SUBSTANCE: composition contains tuberculostatic preparation rifampicin, target additives the main magnesium carbonate or calcium carbonate, calcium or magnesium stearate, milk sugar and a foundation as cacao butter and beeswax, fatty foundation linoleic foundation, "vitepsol H- 15", polyethyleneoxide foundation. Medicinal form of the composition designed as a suppository is of better biological availability of an active substance and high antitubercular activity against the well-known medicinal forms for peroral intake and intravenous injection. It also enables to decrease side effects of rifampicin and prevent the development of pronounced disbacteriosis. EFFECT: higher efficiency of therapy. 8 cl, 4 tbl, 1 dwg, 5 ex